Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
about
Glucocorticoid signaling in the heart: A cardiomyocyte perspectiveA high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repairInducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload.Direct effect of glucocorticoids on glucose-activated adult rat β-cells increases their cell number and their functional mass for transplantation.Primary aldosteronism and salt.Mineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.Future drug discovery in renin-angiotensin-aldosterone system intervention.Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy.Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.Sodium renders endothelial cells sticky for red blood cellsDeletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity.Genomic and rapid effects of aldosterone: what we know and do not know thus far.The reduction in CVD outcomes with antihypertensives: A mandatory goal.Role of smooth muscle cell mineralocorticoid receptor in vascular tone.
P2860
Q28083936-682BF52D-7FF7-4F55-9EB8-7656D3EC3F87Q33635645-B018632E-B84B-478D-AC7D-92F981E708F3Q35852248-B4CF5782-911C-48BE-90A8-E1D033F70332Q36111049-D93E3AB8-A331-4260-98DE-8B525FC19E4FQ38287146-42A0D905-6A62-4B9D-A704-50A23DA9005AQ38667235-47DDAFCB-C05D-4D3D-8C5B-B4D1922D3697Q38679303-E3497A8F-4365-4005-B3D3-8C76F32E1CC7Q39032788-135A0053-CC62-4731-A761-7EA96E1AC8A3Q41112838-F5BF7CDC-5FF8-42DD-87A2-33ED0971C83BQ41606876-C5036B76-4C7C-4586-BA99-5ABD74C004CDQ47120039-CD5BCC1A-13C1-4264-A95A-149959ABDEB7Q51273122-78118059-59C7-406F-85D1-1981591FA16DQ53499525-8DEBDAB0-E7B4-4FC1-BFFE-D39EA0CA0A96Q54319088-8B0D403F-612B-4955-A84F-FE945D0859BB
P2860
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@ast
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@en
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@nl
type
label
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@ast
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@en
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@nl
prefLabel
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@ast
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@en
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@nl
P2860
P356
P1476
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
@en
P2093
John W Funder
P2860
P304
P356
10.2147/IBPC.S13783
P407
P577
2013-10-04T00:00:00Z